Global Cold Remedies Market to Reach $9.7 Billion by 2030

A number of interconnected problems and crises are occurring concurrently, placing the world economy at a critical crossroads. The trouble on the inflation front is still ongoing because it’s unclear how Russia’s war on Ukraine will proceed this year and because of how the war contributed to the current state of unrest around the world.

New York, March 15, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Cold, Cough, And Sore Throat Remedies Industry to reach $9.7 billion by 2030.”

Inflation of food and fuel will continue to be a significant economic issue. The confidence and spending of consumers will be impacted by higher retail inflation. Governments’ efforts to combat inflation by raising interest rates will slow the creation of new jobs, which will have an effect on economic activity and growth. Because of concerns about inflation and weaker demand, businesses are delaying investments, which will result in lower capital expenditure. Developed market economies appear ready to experience a recession due to slower growth and high inflation. The likelihood that the world will experience more severe supply chain pain and manufacturing disruptions this year is increased by worries about new COVID outbreaks and China’s already hazy post-pandemic path. The difficulties we face will become more complex due to the erratic nature of the financial markets, rising trade tensions, stricter regulatory environments, and pressure to mainstream climate change into economic decisions. A difficult year is anticipated for the majority of markets, investors, and consumers in 2023. Nevertheless, opportunities exist for companies and their leaders who can forge ahead while remaining resilient and adaptable.

Global Cold, Cough, And Sore Throat Remedies Market to Reach $9.7 Billion by 2030

The global market for Cold, Cough, and Sore Throat Remedies, which was previously estimated to be worth US$7 billion in 2022, is expected to reach a revised size of US$9.7 billion by 2030, growing at a CAGR of 4.2% from 2022 to 2030. One of the report’s segment analyses, syrups and drops, is anticipated to grow at a 4.7% CAGR and reach US$3.6 billion by the end of the analysis period. With the ongoing post-pandemic recovery taken into account, the growth in the Tablets & Capsules segment is readjusted to a revised 5% CAGR for the following 8 years.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 8.1% CAGR

The U.S. market for treatments for a sore throat, cold, and cough. is estimated at In 2022, US$1.9 billion will be spent. China, the second-largest economy in the world, is anticipated to reach a projected market size of US$2.2 billion by the year 2030, growing at a CAGR of 8.1% from 2022 to 2030. Japan and Canada are two additional noteworthy geographic markets, with growth rates of 0.7% and 3.4%, respectively, predicted for each over the years 2022–2030. Germany is expected to experience growth in Europe at a CAGR of roughly 1.4%.

Select Competitors (Total 243 Featured)